Header

UZH-Logo

Maintenance Infos

Interfering with hedgehog pathway: new avenues for targeted therapy in rhabdomyosarcoma


Manzella, Gabriele; Schäfer, Beat W (2016). Interfering with hedgehog pathway: new avenues for targeted therapy in rhabdomyosarcoma. Current Drug Targets, 17(11):1228-1234.

Abstract

Rhabdomyosarcoma (RMS) is the most frequent pediatric soft-tissue tumor accounting for about 7% of childhood malignancies. Multimodal therapy is the standard treatment for individuals with RMS but generally fails to cure high-risk group patients and can result in long-term side effects. Therefore, understanding the mechanisms driving RMS might help to find new candidate targets for more specific and effective therapeutic modalities. One of the molecular machineries, which is often deregulated in cancer and specifically involved in the tumorigenesis of RMS, is Hedgehog (Hh) signaling. There is increasing evidence that targeting this developmental pathway may hold promise in future treatment strategies for RMS. In this review, we discuss the contribution of the Hh pathway in RMS, the challenges of inhibiting this embryonic signaling in children with an update on recent preclinical data and ongoing clinical trials.

Abstract

Rhabdomyosarcoma (RMS) is the most frequent pediatric soft-tissue tumor accounting for about 7% of childhood malignancies. Multimodal therapy is the standard treatment for individuals with RMS but generally fails to cure high-risk group patients and can result in long-term side effects. Therefore, understanding the mechanisms driving RMS might help to find new candidate targets for more specific and effective therapeutic modalities. One of the molecular machineries, which is often deregulated in cancer and specifically involved in the tumorigenesis of RMS, is Hedgehog (Hh) signaling. There is increasing evidence that targeting this developmental pathway may hold promise in future treatment strategies for RMS. In this review, we discuss the contribution of the Hh pathway in RMS, the challenges of inhibiting this embryonic signaling in children with an update on recent preclinical data and ongoing clinical trials.

Statistics

Citations

Altmetrics

Downloads

100 downloads since deposited on 11 Dec 2015
51 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Children's Hospital Zurich > Medical Clinic
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2016
Deposited On:11 Dec 2015 13:23
Last Modified:02 Feb 2018 09:39
Publisher:Bentham Science Publishers Ltd.
ISSN:1389-4501
OA Status:Green
Publisher DOI:https://doi.org/10.2174/1389450116666150505122604
PubMed ID:25944015

Download

Download PDF  'Interfering with hedgehog pathway: new avenues for targeted therapy in rhabdomyosarcoma'.
Preview
Content: Accepted Version
Filetype: PDF
Size: 519kB
View at publisher